BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7182198)

  • 1. [Physiopathological bases of the medical treatment of portal hypertension].
    Cuccurullo F; Seccia G; Porreca E; Guglielmi MD; Mezzetti A; Tomassetti V; Marzio L
    G Clin Med; 1982 Oct; 63(10):737-43. PubMed ID: 7182198
    [No Abstract]   [Full Text] [Related]  

  • 2. [Rheohepatographic assessment of the therapeutic effects of propranolol on portal hypertension].
    Wu XN
    Zhonghua Yi Xue Za Zhi; 1985 Jul; 65(7):411-3, 446. PubMed ID: 3938325
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of anaprilin for the correction of portal hypertension in liver cirrhosis].
    Bondarenko IP; Dubinskiĭ AA; Tereshkin IG
    Vrach Delo; 1989 Nov; (11):19-22. PubMed ID: 2609578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Medical therapy of portal hypertension due to liver cirrhosis].
    Cerini R; Sperandeo M; Varriale A; De Rosa ML; Cacciatore L
    Recenti Prog Med; 1991 Feb; 82(2):91-9. PubMed ID: 2034876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug therapy of portal hypertension due to cirrhosis.
    Benhamou JP; Lebrec D
    Semin Liver Dis; 1982 Aug; 2(3):227-32. PubMed ID: 6129706
    [No Abstract]   [Full Text] [Related]  

  • 6. Propranolol stereoisomer plasma concentrations and portal haemodynamic response in patients with liver cirrhosis.
    Schepke M; Raab P; Hoppe A; Brensing K; Paar D; Potyka U; Sauerbruch T
    Aliment Pharmacol Ther; 1999 Nov; 13(11):1451-8. PubMed ID: 10571601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Commentary on an abstract. Effects of metoclopramide and domperidone on azygous venous blood flow in patients with cirrhosis and portal hypertension].
    Sauerbruch T
    Z Gastroenterol; 1987 Sep; 25(9):612-3. PubMed ID: 3673147
    [No Abstract]   [Full Text] [Related]  

  • 8. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J; Picabea E; Gamen M; Villavicencio R; Bordato J; Bessone F; Tanno H; Palazzi J; Sarano H; Pozzoli L
    Hepatology; 1993 Sep; 18(3):477-84. PubMed ID: 8359793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodynamics in the isolated cirrhotic liver.
    Zipprich A
    J Clin Gastroenterol; 2007; 41 Suppl 3():S254-8. PubMed ID: 17975473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment of portal hypertension.
    González-Abraldes J; Bosch J; García-Pagán JC
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1407-13. PubMed ID: 11890356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of endothelin in systemic and portal resistance in cirrhosis.
    Angus PW
    Gut; 2006 Sep; 55(9):1230-2. PubMed ID: 16905694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of nitrosorbide, korinfar and obzidan on the hemodynamics of patients with chronic hepatitis and liver cirrhosis based on the data acute drug trials].
    Vorob'ev LP; Maev IV
    Farmakol Toksikol; 1991; 54(5):54-7. PubMed ID: 1800153
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of propranolol and nitroglycerin on portal pressure and the mechanism of their reducing portal pressure.
    Terada M; Notsumata K; Unoura M; Kobayashi K; Hattori N
    J Gastroenterol Hepatol; 1989; 4 Suppl 1():254-8. PubMed ID: 2519070
    [No Abstract]   [Full Text] [Related]  

  • 15. [Echographic and hemodynamic indicators in liver cirrhosis with portal hypertension].
    Rikhsieva LE; Akhmedzhanova ShSh; Miasnik BN
    Sov Med; 1989; (2):13-5. PubMed ID: 2658117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheohepatogram as a parameter in assessing immediate effects of propranolol on portal hypertension.
    Wu XN; Gu JK; Wang GL; Ding MM
    Chin Med J (Engl); 1986 Jan; 99(1):27-31. PubMed ID: 3089702
    [No Abstract]   [Full Text] [Related]  

  • 17. [The effects of cimetidine on splanchnic hemodynamics in cirrhotic patients with portal hypertension].
    Li S
    Zhonghua Wai Ke Za Zhi; 1993 Apr; 31(4):207-9. PubMed ID: 8275833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hemodynamics in patients with liver cirrhosis and portal hypertension syndrome].
    Ershov IuA; Pomelova LA; Kulagina TV; Kislukhin VV; Morozov VA
    Sov Med; 1984; (7):17-23. PubMed ID: 6484727
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hemodynamic interrelations in portal hypertension caused by hepatic cirrhosis].
    Garcia Civera R; Benages Martínez A; Lopez Merino F; Garcia-Conde Gomez FJ
    Rev Esp Enferm Apar Dig; 1972 Jul; 38(1):19-34. PubMed ID: 5069488
    [No Abstract]   [Full Text] [Related]  

  • 20. [Physiopathologic basis of medical therapy of portal hypertension in cirrhosis].
    Gatta A; Bolognesi M; Sacerdoti D; Merkel C
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():39S-47S. PubMed ID: 9004819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.